Skip to main content
Clinical Trials/NCT04597840
NCT04597840
Recruiting
Not Applicable

Multicenter, Prospective, Longitudinal and Randomized Comparison of Both the Clinical and Economic Impact of Biosynthetic Absorbable Mesh to the Surgical Standard of Care in Contaminated Incisional Hernia Repair

Hospices Civils de Lyon1 site in 1 country108 target enrollmentMay 25, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ventral Hernia Repair
Sponsor
Hospices Civils de Lyon
Enrollment
108
Locations
1
Primary Endpoint
Rate of incisional hernia recurrence
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Incisional hernia is one of the most common complications of abdominal surgery and carries a significant burden for both patients and the economic health service. However, no consensus for the surgical treatment of incisional hernia in contaminated field is currently available. The purpose of the COMpACT-BIO study is to investigate the clinical and economic benefit of the use of biosynthetic mesh in contaminated incisional hernia repair.

Detailed Description

The current standard of incisional hernia repair is reinforcement with permanent synthetic mesh. However, permanent synthetic mesh is contraindicated in contaminated surgical field due to higher risk of postoperative infection. In order to resist to infection, absorbable meshes, such as biological and biosynthetic meshes, have been developped. However, some controversies exist about the clinical benefit of biological meshes in the long term. Reasons for theses controversies are their overall risk of complication and recurrence and the lack of consensus in which surgical technique to apply. Moreover, the financial cost of biological meshes is very high. Recently developed, biosynthetic meshes appear to be a promising option ; Compared to biological meshes, they seem to have several advantages. However, such data demonstrating the beneficial use of biosynthetic mesh in contaminated incisional hernia repair is not available. In this regard, the COMpACT-BIO study aims to investigate the clinical and economic benefit of the use of biosynthetic mesh in contaminated incisional hernia repair in comparison to the standard of repair. This is a multicenter, prospective, longitudinal and randomized study, which also offers a standardized technique of repair.

Registry
clinicaltrials.gov
Start Date
May 25, 2021
End Date
October 2024
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Rate of incisional hernia recurrence

Time Frame: 3 years after surgery

The rate of incisional hernia recurrence will be evaluated by radiologic imaging.

Secondary Outcomes

  • Rate of screening failure(48 months after the start of the study)
  • Incidence of re-operation related to incisional hernia repair(For 3 years after surgery)
  • Days of hospitalization related to incisional hernia repair(For 3 years after surgery)
  • Incidence of wound events(1 month from surgery date, then 3-, 6- 12-, 24- and 36 months from surgery date)
  • Assessment of health care consumption related to health care status(pre and post-surgery (1 month from surgery date, then 3, 6, 12, 24 and 36 months from surgery date).)
  • Incidence of revision surgery or interventional radiologic procedure(1 month from surgery date, then 3-, 6- 12-, 24- and 36 months from surgery date)
  • Rate of early incisional hernia recurrence(1 month from surgery date, then 3-, 6- 12-, 24- and 36 months from surgery date)
  • Incisional hernia specific quality-of-life assessment(Pre and post-surgery (1 month from surgery date, then 3, 6, 12, 24 and 36 months from surgery date).)
  • Number of healing days(1 month from surgery date, then 3-, 6- 12-, 24- and 36 months from surgery date)

Study Sites (1)

Loading locations...

Similar Trials